Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -0.43% | 688.87 | 2.6% | $679.29m | |
| MRNA | Moderna, Inc. | 0.15% | 118.25 | 0.0% | $616.94m | |
| AMGN | Amgen, Inc. | -1.32% | 225.40 | 1.4% | $605.62m | |
| BIIB | Biogen, Inc. | 1.03% | 267.00 | 1.8% | $554.62m | |
| GILD | Gilead Sciences, Inc. | -2.19% | 61.69 | 1.0% | $514.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.11% | 289.54 | 1.9% | $401.56m | |
| ILMN | Illumina, Inc. | -1.56% | 190.79 | 3.2% | $338.76m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 4.40% | 4.27 | 0.7% | $298.49m | |
| SAVA | Cassava Sciences, Inc. | -2.90% | 41.82 | 0.0% | $189.63m | |
| BNTX | BioNTech SE | 0.96% | 134.88 | 0.0% | $112.19m | |
| NVAX | Novavax, Inc. | -1.99% | 18.20 | 75.6% | $84.03m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.34% | 84.77 | 4.2% | $82.56m | |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 9.35% | 13.69 | 0.0% | $78.90m | |
| PRTA | Prothena Corp. Plc | 1.95% | 60.63 | 13.8% | $78.20m | |
| CRSP | CRISPR Therapeutics AG | 1.33% | 65.35 | 0.6% | $76.10m |
Company Profile
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.